Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial.
Rubio-Gomis E, Martinez-Mir I, Morales-Olivas FJ, Martorell-Aragones A, Palop-Larrea V, Bernalte-Sesé A, Cerda-Mir JC, Polo-Martín P, Febrer I, Aranda-Grau L, Llosa-Cortes I, Tejedor-Sanz MJ, Julia-Benito JC, Alvarez-de-Laviada-Mulero T, Planelles-Cantarino MV, Apolinar-Valiente E, Loriente-Tur M, Abella-Bazataqui AM, Alvarez-Gonzalez I, Morales-Carpi C, Burches-Greus ME, Ferrer-Bautista AB, Felix-Toledo R, Marmaneu-Laguia D, Garcia-Martinez VE, Beltran-Marques MA, Rodriguez-Gracia B.
Rubio-Gomis E, et al. Among authors: febrer i.
Allergol Immunopathol (Madr). 2018 Jul-Aug;46(4):378-384. doi: 10.1016/j.aller.2017.12.001. Epub 2018 Jan 17.
Allergol Immunopathol (Madr). 2018.
PMID: 29373242
Clinical Trial.